Cost effectiveness of bariatric surgery in patients with obesity related comorbidities : A retrospective study
Copyright: © 2021 Journal of Family Medicine and Primary Care..
Background and Aim: Bariatric surgery has been reported to be an effective but expensive method for obesity management. This study aimed to determine the economic benefit for patients who underwent bariatric surgery.
Methodology: We conducted a retrospective chart review of patients who underwent bariatric surgery and was on medications for obesity-related comorbidities at the Obesity Research Center in King Khalid University Hospital, Riyadh, Saudi Arabia. Data on the use and cost of medications before and after bariatric surgery were collected.
Results: A total of 266 patients, 107 males (40.23%), and 159 Females (59.77%) with a mean age of 41.06 years were included in the study. There was a reduction in the mean number of medications used by patients before and 1-year post-op (before: 1.84, after: 0.52), with a significant reduction in the cost of medications (SAR5152.24 before, and SAR1695.36 after, 67% reduction, P < 0.001). Patients < 32 years old had the most reduction in medications cost (76.64% reduction). No significant difference in the cost reduction after surgery between genders (P = 0.971). There were significant reductions in numbers of out-patient clinic visits (2.26 ± 2.43 to 1.57 ± 1.42) and in-patient hospitalizations (0.31 ± 0.57 to 0.10 ± 0.36) after surgery (P < 0.001 and P < 0.001, respectively).
Conclusion: Bariatric surgery can be considered as a cost-effective treatment for patients with obesity-related comorbidities. A significant reduction has been found in post-operative medications cost, out-patient clinic visits and in-patient hospitalizations after bariatric surgery.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Journal of family medicine and primary care - 10(2021), 12 vom: Dez., Seite 4418-4422 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dohayan Al-Dohayan, Abdullah [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bariatric surgery |
|---|
| Anmerkungen: |
Date Revised 15.03.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4103/jfmpc.jfmpc_877_21 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338113975 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338113975 | ||
| 003 | DE-627 | ||
| 005 | 20231225235936.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/jfmpc.jfmpc_877_21 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1127.xml |
| 035 | |a (DE-627)NLM338113975 | ||
| 035 | |a (NLM)35280632 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dohayan Al-Dohayan, Abdullah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cost effectiveness of bariatric surgery in patients with obesity related comorbidities |b A retrospective study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2021 Journal of Family Medicine and Primary Care. | ||
| 520 | |a Background and Aim: Bariatric surgery has been reported to be an effective but expensive method for obesity management. This study aimed to determine the economic benefit for patients who underwent bariatric surgery | ||
| 520 | |a Methodology: We conducted a retrospective chart review of patients who underwent bariatric surgery and was on medications for obesity-related comorbidities at the Obesity Research Center in King Khalid University Hospital, Riyadh, Saudi Arabia. Data on the use and cost of medications before and after bariatric surgery were collected | ||
| 520 | |a Results: A total of 266 patients, 107 males (40.23%), and 159 Females (59.77%) with a mean age of 41.06 years were included in the study. There was a reduction in the mean number of medications used by patients before and 1-year post-op (before: 1.84, after: 0.52), with a significant reduction in the cost of medications (SAR5152.24 before, and SAR1695.36 after, 67% reduction, P < 0.001). Patients < 32 years old had the most reduction in medications cost (76.64% reduction). No significant difference in the cost reduction after surgery between genders (P = 0.971). There were significant reductions in numbers of out-patient clinic visits (2.26 ± 2.43 to 1.57 ± 1.42) and in-patient hospitalizations (0.31 ± 0.57 to 0.10 ± 0.36) after surgery (P < 0.001 and P < 0.001, respectively) | ||
| 520 | |a Conclusion: Bariatric surgery can be considered as a cost-effective treatment for patients with obesity-related comorbidities. A significant reduction has been found in post-operative medications cost, out-patient clinic visits and in-patient hospitalizations after bariatric surgery | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bariatric surgery | |
| 650 | 4 | |a cost-effectiveness | |
| 650 | 4 | |a medication cost | |
| 650 | 4 | |a obesity | |
| 700 | 1 | |a Qamhiah, Danah Farhan |e verfasserin |4 aut | |
| 700 | 1 | |a Abukhalaf, Abdulelah Adnan |e verfasserin |4 aut | |
| 700 | 1 | |a Alomar, Ali Abdullah |e verfasserin |4 aut | |
| 700 | 1 | |a Almutairi, Faris Jamal |e verfasserin |4 aut | |
| 700 | 1 | |a Alsalame, Nayef Mosleh |e verfasserin |4 aut | |
| 700 | 1 | |a Alasbali, Majed Mohammed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of family medicine and primary care |d 2012 |g 10(2021), 12 vom: Dez., Seite 4418-4422 |w (DE-627)NLM23498807X |x 2249-4863 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2021 |g number:12 |g month:12 |g pages:4418-4422 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/jfmpc.jfmpc_877_21 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2021 |e 12 |c 12 |h 4418-4422 | ||